Adverse Drug Reaction Classification System

         

Pharmaceutical Information
Drug Name Clindamycin phosphate
Drug ID BADD_D00487
Description Not Available
Indications and Usage Not Available
Marketing Status Not Available
ATC Code Not Available
DrugBank ID Not Available
KEGG ID D01073
MeSH ID C007084
PubChem ID 32603
TTD Drug ID Not Available
NDC Product Code 51927-0273; 45802-263; 50090-5779; 51672-1399; 51672-1400; 53002-8371; 63323-282; 63629-8632; 71872-7165; 71872-7192; 73473-300; 43538-173; 45802-042; 0009-3051; 53002-8370; 59762-3743; 59762-5009; 0338-3814; 0338-9549; 71872-7191; 71872-7197; 25021-115; 0009-0728; 45802-660; 0009-5095; 59762-3744; 71872-7189; 71872-7253; 63629-8630; 68462-866; 52946-0603; 16714-246; 0168-0202; 0168-0277; 0009-0775; 0009-0870; 0009-4073; 51672-4081; 69238-2030; 0338-3612; 63629-8629; 63629-8634; 0404-9837; 69238-2031; 71428-003; 71872-7284; 39635-0001; 49711-0116; 67321-302; 17478-122; 45802-900; 0338-3616; 63629-8628; 63629-9309; 0404-9838; 68682-462; 71872-7194; 71872-7199; 71872-7200; 72578-084; 58598-0003; 68981-026; 16714-161; 43538-172; 0009-0901; 0338-3410; 0338-9545; 0338-9553; 63629-8631; 71872-7123; 71872-7186; 72611-634; 72611-639; 72611-642; 72611-645; 73473-302; 10135-691; 62991-3171; 17478-121; 21922-036; 43066-995; 0009-0302; 0168-0201; 45802-128; 0009-3329; 0009-3448; 0009-7667; 50090-6072; 51672-4194; 63629-8633; 63629-9459; 68788-7990; 38779-0006; 69132-003; 79572-007; 43066-993; 43538-179; 45802-562; 0338-4114; 70771-1414; 46204-0120; 17478-120; 43538-170; 0168-0203; 0009-0902
UNII EH6D7113I8
Synonyms clindamycin phosphate | clindamycin-2-phosphate | Clindesse | Clindets | Cleocin phosphate
Chemical Information
Molecular Formula C18H34ClN2O8PS
CAS Registry Number 24729-96-2
SMILES CCCC1CC(N(C1)C)C(=O)NC(C2C(C(C(C(O2)SC)OP(=O)(O)O)O)O)C(C)Cl
Chemical Structure
ADRs Induced by Drug
*The priority for ADR severity classification is based on FAERS assessment, followed by the most severe level in CTCAE rating. If neither is available, it will be displayed as 'Not available'.
**The 'Not Available' level is hidden by default and can be restored by clicking on the legend twice..
ADR Term ADReCS ID ADR Frequency (FAERS) ADR Severity Grade (FAERS) ADR Severity Grade (CTCAE)
Oliguria20.01.03.004--Not Available
Pain08.01.08.004--
Polyarthritis15.01.01.005--Not Available
Proteinuria20.02.01.011--
Pruritus23.03.12.001--
Pseudomembranous colitis11.02.02.002; 07.19.01.003--Not Available
Rash23.03.13.001--Not Available
Rash maculo-papular23.03.13.004--
Rectal haemorrhage24.07.02.018; 07.12.03.001--
Seborrhoea23.02.07.001--Not Available
Seborrhoeic dermatitis23.03.04.018--Not Available
Sinusitis22.07.03.007; 11.01.13.005--
Skin discolouration23.03.03.005--Not Available
Skin exfoliation23.03.07.003--Not Available
Skin irritation23.03.04.009--Not Available
Stevens-Johnson syndrome10.01.01.045; 23.03.01.007; 12.03.01.014; 11.07.01.005--
Swelling face08.01.03.100; 23.04.01.018; 10.01.05.018--Not Available
Tachycardia02.03.02.007--Not Available
Thrombocytopenia01.08.01.002--Not Available
Thrombophlebitis24.01.02.001--Not Available
Tonsillitis22.07.03.008; 11.01.13.006--Not Available
Tracheitis22.07.03.009; 11.01.13.007--
Upper respiratory tract infection22.07.03.011; 11.01.13.009--
Urinary tract infection20.08.02.001; 11.01.14.004--
Urticaria23.04.02.001; 10.01.06.001--
Vaginal discharge21.08.02.002--
Vaginal infection21.14.02.002; 11.01.10.002--
Vertigo17.02.12.002; 04.04.01.003--
Vomiting07.01.07.003--
Vulvovaginal candidiasis21.14.02.003; 11.03.03.005--Not Available
The 3th Page    First    Pre   3 4    Next   Last    Total 4 Pages